Christina Wu

Title: Christina Wu: Innovator in Immunotherapy Research

Introduction

Christina Wu is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of immunotherapy, particularly in the context of head and neck squamous cell carcinomas. With a total of 2 patents, her work focuses on the intricate mechanisms of cancer biology and potential therapeutic targets.

Latest Patents

One of Christina Wu's latest patents is centered on the Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas. The diverse receptor-ligand pairs of the Wnt and frizzled (Fzd) families play crucial roles during embryonic development and may be overexpressed in cancers that arise from immature cells. Her research investigated the mRNA levels and expression levels of 5 Wnt (Wnt-1, 5a, 7a, 10b, 13) and 2 Fzd (Fzd-2, 5) genes in 10 head and neck squamous carcinoma cell lines (HNSCC). Additionally, anti-Wnt-1 antibodies were utilized to study the Wnt/Fzd signaling pathway. The findings indicate that HNSCC cell lines overexpress one or more Wnt and Fzd genes, suggesting that the proliferation and survival of a subset of HNSCC may depend on the Wnt/Fzd pathway. Therefore, the Wnt and Fzd receptors may serve as valuable targets for immunotherapy of this common cancer.

Career Highlights

Christina Wu is affiliated with the University of California, where she conducts her research and contributes to the academic community. Her innovative work has garnered attention and recognition in the field of cancer research.

Collaborations

Some of her notable coworkers include Chae-Seo Rhee and Maripat Corr, who collaborate with her on various research projects.

Conclusion

Christina Wu's contributions to immunotherapy research highlight her role as an influential inventor in the field. Her work on Wnt and frizzled receptors opens new avenues for potential cancer treatments.